Divya Murthy

Divya Murthy

Auto-generated profile, based on publicly available information

Divya Murthy

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Cancer Cell
Verified
Journal Article
Closed access
SSSurendra K. Shukla
Surendra K. Shukla
VPVinee Purohit
Vinee Purohit
KMKamiya Mehla
Kamiya Mehla
VGVenugopal Gunda
Venugopal Gunda
NCNina V. Chaika
Nina V. Chaika
PSPankaj Singh
Pankaj Singh

1 March 2024 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DMDivya Murthy
Divya Murthy
KAKuldeep S. Attri
Kuldeep S. Attri
SSSurendra K. Shukla
Surendra K. Shukla
RAVI THAKURRAVI THAKUR
RAVI THAKUR
NCNina V. Chaika
Nina V. Chaika
PSPankaj Singh
Pankaj Singh
The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP–seq and RNA–seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated acetylation of SP1 at the lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2–SP1–SAT1 axis diminished the tumour burden in mouse models. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2–SP1–SAT1 axis.

4 April 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
DMDivya Murthy
Divya Murthy
KAKuldeep S. Attri
Kuldeep S. Attri
PSPankaj Singh
Pankaj Singh
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic options. Genetic alterations in key signaling pathways found in early pancreatic lesions are pivotal for the development and progression of pancreatic intraepithelial neoplastic lesions into invasive carcinomas. More than 90% of PDAC tumors harbor driver mutations in K-Ras that activate various downstream effector-signaling pathways, including the phosphoinositide-3-kinase (PI3K) pathway. The PI3K pathway also responds to stimuli from various growth factor receptors present on the cancer cell surface that, in turn, modulate downstream signaling cascades. Thus, the inositide signaling acts as a central node in the complex cellular signaling networks to impact cancer cell growth, motility, metabolism, and survival. Also, recent publications highlight the importance of PI3K signaling in stromal cells, whereby PI3K signaling modifies the tumor microenvironment to dictate disease outcome. The high incidence of mutations in the PI3K signaling cascade, accompanied by activation of parallel signaling pathways, makes PI3K a promising candidate for drug therapy. In this review, we describe the role of PI3K signaling in pancreatic cancer development and progression. We also discuss the crosstalk between PI3K and other major cellular signaling cascades, and potential therapeutic opportunities for targeting pancreatic ductal adenocarcinoma.

1 August 2017 in Cancer Letters
Verified
Journal Article
Closed access
JAJaime Abrego
Jaime Abrego
VGVenugopal Gunda
Venugopal Gunda
EVEnza Vernucci
Enza Vernucci
SSSurendra K. Shukla
Surendra K. Shukla
RKRyan J. King
Ryan J. King
PSPankaj Singh
Pankaj Singh

6 November 2023 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
CHChunbo He
Chunbo He
DWDi Wang
Di Wang
SSSurendra K. Shukla
Surendra K. Shukla
THTuo Hu
Tuo Hu
RAVI THAKURRAVI THAKUR
RAVI THAKUR
KMKamiya Mehla
Kamiya Mehla
Nutritional factors play crucial roles in immune responses. The tumor-caused nutritional deficiencies are known to affect antitumor immunity. Here, we demonstrate that pancreatic ductal adenocarcinoma (PDAC) cells can suppress NK-cell cytotoxicity by restricting the accessibility of vitamin B6 (VB6). PDAC cells actively consume VB6 to support one-carbon metabolism, and thus tumor cell growth, causing VB6 deprivation in the tumor microenvironment. In comparison, NK cells require VB6 for intracellular glycogen breakdown, which serves as a critical energy source for NK-cell activation. VB6 supplementation in combination with one-carbon metabolism blockage effectively diminishes tumor burden in vivo. Our results expand the understanding of the critical role of micronutrients in regulating cancer progression and antitumor immunity, and open new avenues for developing novel therapeutic strategies against PDAC. Significance: The nutrient competition among the different tumor microenvironment components drives tumor growth, immune tolerance, and therapeutic resistance. PDAC cells demand a high amount of VB6, thus competitively causing NK-cell dysfunction. Supplying VB6 with blocking VB6-dependent one-carbon metabolism amplifies the NK-cell antitumor immunity and inhibits tumor growth in PDAC models. This article is featured in Selected Articles from This Issue, p. 5

26 July 2017 in Autophagy
Verified
Journal Article
Open access
ARAmrita Ramkumar
Amrita Ramkumar
DMDivya Murthy
Divya Murthy
DRDesingu Ayyappa Raja
Desingu Ayyappa Raja
ASArchana Singh
Archana Singh
AKAnusha Krishnan
Anusha Krishnan
RGRajesh S. Gokhale
Rajesh S. Gokhale
Macroautophagy/autophagy is a dynamic and inducible catabolic process that responds to a variety of hormonal and environmental cues. Recent studies highlight the interplay of this central pathway in a variety of pathophysiological diseases. Although defective autophagy is implicated in melanocyte proliferation and pigmentary disorders, the mechanistic relationship between the 2 pathways has not been elucidated. In this study, we show that autophagic proteins LC3B and ATG4B mediate melanosome trafficking on cytoskeletal tracks. While studying melanogenesis, we observed spatial segregation of LC3B-labeled melanosomes with preferential absence at the dendritic ends of melanocytes. This LC3B labeling of melanosomes did not impact the steady-state levels of these organelles but instead facilitated their intracellular positioning. Melanosomes primarily traverse on microtubule and actin cytoskeletal tracks and our studies reveal that LC3B enables the assembly of microtubule translocon complex. At the microtubule-actin crossover junction, ATG4B detaches LC3B from melanosomal membranes by enzymatic delipidation. Further, by live-imaging we show that melanosomes transferred to keratinocytes lack melanocyte-specific LC3B. Our study thus elucidates a new role for autophagy proteins in directing melanosome movement and reveal the unconventional use of these proteins in cellular trafficking pathways. Such crosstalk between the central cellular function and housekeeping pathway may be a crucial mechanism to balance melanocyte bioenergetics and homeostasis.